Skip to content
Black Friday — 30% OFFFree shipping on orders of C$99 or more
  1. Home
  2. Longevity & Cellular Health
  3. TB-500 (0.5mg/capsule), 60 Capsules
Longevity

TB-500 (0.5mg/capsule), 60 Capsules

TB-500 (Thymosin Beta-4) capsules provide an oral administration format for the 43-amino-acid actin-binding peptide, enabling oral route investigations alongside the lyophilized vial format.

Presentation: TB-500 (0.5mg/capsule), 60 Capsules.

Illustrative packaging generated with AI.

Original price was: C$254.95.Current price is: C$178.47.

Available on request in Canada

Ask an advisor
An advisor contacts you and the partner pharmacy checks whether and how it can proceed. A valid prescription, or an assessment through an authorized telemedicine service, may be required.
  • Partner pharmacy
  • Personal assistance
  • Discreet delivery
  • Presentation
    TB-500 (0.5mg/capsule), 60 Capsules

Shipping & Delivery

  • Normally dispatched within 24 hours of payment confirmation.
  • USPS Regular Shipping · C$11.95 · Approx. 3–5 business days
  • FedEx 2 Days Delivery · C$28.99 · Approx. 2 business days
  • FedEx Overnight Delivery · C$40.99 · Approx. 1 business day

For laboratory research only.

Not for human or veterinary use.

Composition and product details

Overview

TB-500 (Thymosin Beta-4) capsules provide an oral administration format for the 43-amino-acid actin-binding peptide, enabling oral route investigations alongside the lyophilized vial format.

As with the injectable format, the active compound interacts with G-actin through its LKKTET motif, influencing actin polymerization dynamics, cytoskeletal organization, and cell migration–associated signaling pathways.

Experimental investigations have examined TB-500 in relation to actin-regulatory mechanisms, molecular signaling networks, and pathway-specific processes involved in cytoskeletal biology.

Research applications include oral versus parenteral comparative studies, actin cytoskeletal pathway investigation, cell migration signaling research, and mechanistic evaluation of actin-associated regulatory systems.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Properties

Chemical Formula C212H350N56O78S
Synonyms Thymosin Beta-4, Tβ4, TB500 capsules
Molar Mass 889.01 g/mol
CAS Number 77591-33-4
PubChem CID 16132341
Total Compound Content 30 mg (0.5 mg per capsule)
Shelf Life 36 months

Research

TB-500 (Thymosin Beta-4 analogue) capsules (0.5 mg/capsule) provide an oral administration format for the 43-amino-acid actin-binding peptide. The primary characterized mechanism—LKKTET motif-mediated interaction with G-actin—is identical to the injectable vial format. The capsule format enables investigation of alternative administration routes and provides a useful platform for studies examining compound transport, peptide stability, and route-dependent signaling characteristics. Experimental research has examined TB-500 in relation to actin polymerization dynamics, cytoskeletal organization, cell migration-associated pathways, and molecular signaling networks linked to actin-regulatory systems. The oral format is also useful for studies requiring non-parenteral delivery approaches or investigations of peptide-associated signaling processes across distinct experimental environments. Independently third-party HPLC-tested; COA available per batch.

FAQ

What is the research basis for the TB-500 capsule format?

TB-500 capsules provide an alternative formulation format for investigating the same 43-amino-acid actin-binding peptide found in vial preparations. Experimental studies have examined formulation-dependent characteristics, peptide stability properties, compound-processing mechanisms, and actin-associated signaling pathways.

The capsule format is useful for comparative investigations examining how different formulations influence experimental parameters while retaining the same underlying molecular structure.

What is the difference between TB-500 capsules and TB-500 vials for laboratory research?

TB-500 capsules and TB-500 vials contain the same active compound and share the same core actin-associated mechanism. The primary distinction is the formulation format, allowing researchers to investigate different preparation strategies, formulation characteristics, and experimental design variables. The compound itself remains unchanged, while the format provides flexibility for a range of laboratory research applications.

Does the capsule format of TB-500 change its mechanism of action compared to vial preparations?

No. The core mechanism involving G-actin interaction through the LKKTET motif is intrinsic to the TB-500 molecule and remains unchanged regardless of formulation format. Experimental differences between formats relate to formulation characteristics rather than the underlying molecular mechanism.

This makes the capsule format useful for comparative investigations of actin-regulatory pathways, peptide-associated signaling processes, and formulation-dependent experimental variables.

Capsule excipients are not specified in the available product documentation.

Original price was: C$254.95.Current price is: C$178.47.